NTT
16.3.2022 15:02:09 CET | Business Wire | Press release
NTT Ltd. today announced its collaboration with Schneider Electric , the leader in the digital transformation of energy management and automation, to deliver Private 5G (P5G) – an on-premise private network solution and digitization enabling platform that can dramatically advance digital solutions in the manufacturing environment. The long-standing partnership between NTT and Schneider Electric builds on existing joint strategic innovations that help clients achieve efficiency and sustainability goals with advanced digital processes within the Industry X sectors.
In early 2022, the P5G platform will be piloted at Schneider’s Lexington Smart Factory , the first of Schneider Electric’s U.S. plants to become a Smart Factory showcase site leveraging IoT connectivity, Edge analytics, and predictive analytics to drive energy efficiency and further sustainability goals. The P5G will power key use-cases that solve challenges around equipment availability, machine performance, and product quality. For example, the companies will integrate ‘machine vision’ capabilities (industrial cameras with specialized optics) into existing factory and warehouse automation systems, that identify faults as well as wear and tear for incident root cause in near real-time.
Through co-innovation, the solution will provide a model for operational integrity management that scales across a broad footprint of global factory environments to power Industry 4.0, enabling Network Edge platforms.
Additional P5G use-cases to be addressed include:
- Unfettered connectivity for improved management of AGV devices across a factory footprint that yields more efficient and accurate workflow systems.
- Machine vision application to detect anomalies in machine performance to ensure high performance, availability, and quality of product.
- Augmented reality solutions that enable remote worker support for enhanced equipment maintenance and management and worker experience.
“With this strategic partnership, we are confident that NTT's P5G solution will support Schneider Electric business and service level objectives with a powerful machine vision solution that solves for operational continuity and performance throughout the Lexington and Lincoln plant facilities,” said Shahid Ahmed, EVP New Ventures and Innovation at NTT. “Our P5G platform brings full-stack managed services, process workflow and IoT application integration capabilities that both addresses strategic objectives towards factory high performance and net zero carbon emission goals.”
“In partnering with NTT, Schneider Electric further extends its manufacturing expertise along with data center and network solutions to drive innovations for self-contained Edge Private 5G use-cases,” said Luc Rémont, Executive Vice President International Operations at Schneider Electric.
“Above and beyond superior security and control offered through this partnership, wireless networks offer superior benefits over a wired network from a sustainability perspective – smaller copper cabling footprint means minimizing energy usage and aligning to our net-zero carbon goals,” Rémont added.
To further the partnership, NTT will deploy its Private 5G services and data centers with Schneider Electric technologies, including a prefabricated data center to integrate and test its edge offerings using EcoStruxure™ solutions. This is expected to be 100% operative in Schneider Electric factories during the 2nd QTR 2022.
Schneider Electric’s prefabricated data centers help cloud and service providers scale quickly and efficiently while also meeting their sustainability goals. In addition to a 60% reduction in up time compared to traditional data centers, these prefabricated modular data centers are manufactured with sustainable construction methods and features that boost reliability, optimize operational energy savings, and leave a smaller environmental footprint.
ENDS
About NTT Ltd.
NTT Ltd. is a leading, global technology services company. To help our clients achieve their digital transformation goals, we use our global capabilities, expertise, and full-stack technology services delivered through our integrated services platform. As their long-term strategic partner, we help them enhance customer and employee experience, transform their cloud strategy, modernize their networks and strengthen their cybersecurity. And across their transformation priorities, we automate their business processes and IT, drawing insights and analytics from their core business data. As a global ICT provider, we employ more than 50,000 people across 57 countries, trading in 73 countries and delivering services in over 200 countries and regions. Together we enable the connected future. Visit us at services.global.ntt
About Schneider Electric
Schneider’s purpose is to empower all to make the most of our energy and resources , bridging progress and sustainability for all. We call this Life Is On. Our mission is to be your digital partner for Sustainability and Efficiency. We drive digital transformation by integrating world-leading process and energy technologies, end-point to cloud connecting products, controls, software and services, across the entire lifecycle, enabling integrated company management, for homes, buildings, data centers, infrastructure, and industries. We are the most local of global companies . We are advocates of open standards and partnership ecosystems that are passionate about our shared Meaningful Purpose, Inclusive, and Empowered values.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220315005108/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom